Hypokalemic Periodic Paralysis: A Review of Pathophysiology, Clinical Features, and Treatment
Lusiadas Scientific Journal · 23.11.2022
DOI: 10.48687/lsj.140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lusiadas Scientific Journal, erschienen am 23.11.2022. Verfasst von Ferreira Cristina und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Hypokalemic periodic paralysis is a rare genetic skeletal muscle channelopathy characterized by recurrent attacks of tetraparesia associated with hypokalemia. Mutations in skeletal muscle sodium and calcium channels are responsible for the pathophysiology of this condition and each mutation seem to have different implication in both phenotype and response to treatment. Patients with hypokalemic periodic paralysis present with recurrent muscle weakness and hypokalemia, frequently after exercise or copious meals, but are symptom free between attacks. Although potassium administration is the mainstay of acute treatment, carbonic anhydrase inhibitors play a significant role in prophylactic treatment. In this article, we aimed to review the pathophysiology, clinical features, and treatment options of hypokalemic periodic paralysis.
Schlagwörter
Zitieren
APA
Cristina, F., Sérgio, Espadinha, & Victor (2022). Hypokalemic Periodic Paralysis: A Review of Pathophysiology, Clinical Features, and Treatment. Lusiadas Scientific Journal. https://doi.org/10.48687/lsj.140
Vancouver
Cristina F, Sérgio, Espadinha, Victor. Hypokalemic Periodic Paralysis: A Review of Pathophysiology, Clinical Features, and Treatment. Lusiadas Scientific Journal. 2022. doi:10.48687/lsj.140
BibTeX
@article{Cristina2022,
author = {Cristina, Ferreira and Sérgio and Espadinha and Victor},
title = {Hypokalemic Periodic Paralysis: A Review of Pathophysiology, Clinical Features, and Treatment},
journal = {Lusiadas Scientific Journal},
year = {2022},
doi = {10.48687/lsj.140}
}
EUVIMED